By exploring the roles of cGAS-STING in ovarian, endometrial, and cervical cancers, we will discuss how this pathway contributes to immune surveillance, inflammation, and the tumor microenvironment, offering insights into potential therapeutic targets for improving cancer treatment outcomes (18). This evidence concerns the gene STING1 and cancer.